Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
Sahajanand Medical Technologies Limited reported no FY26 output from Hyderabad transcatheter aortic valve implantation and occluder lines, while Surat’s drug-coated balloon line used 1.81% of capacity.
Sahajanand Medical Technologies Limited reported Rs 320.633 crore of consolidated borrowings at June 30, 2026, with 79.34% current under loan agreements.
Sahajanand Medical Technologies disclosed $300,000 in annual contracts with director-led firms, while its chairman emeritus is entitled to Rs 20.4 lakh of monthly office rent.
Sahajanand Medical Technologies Limited’s IPO sells 13,822,116 existing shares, or 13.60% of pre-offer capital, with no proceeds going to the company.
Supraflex Cruz supplied 39.00% of Sahajanand revenue in the three months ended June 30, 2026, down from 47.84% in Fiscal 2024.
SMT’s shareholder agreement ends at trading, while NHP EA and Samara may each nominate one director if separately holding at least 10% post-offer.
Sahajanand Medical Technologies IPO opens 15 Oct 2026 as an OFS of 13,822,116 shares (13.60% pre-offer). No fresh issue; price band and issue size awaited.
The Company’s promoters hold 98.46% of issued shares before the IPO, with P N S Business and Rashin Consultants owning 125,104,800 shares.
Fusion CX borrowings reached Rs 299.46 crore on August 31, 2026, with secured working-capital facilities comprising Rs 189.79 crore, or 63.38% of debt.
Fusion CX Limited reports promoters held 125,104,800 shares, or 96.21% fully diluted, while two corporate vehicles were ultimately controlled by its managing directors.
Fusion CX revenue rose 83.4% to Rs 1,818.138 crore in FY26, while profit for the year climbed 368.4% to Rs 169.840 crore.
Outsourced digital customer experience is forecast to reach Rs 2.5585 lakh crore by 2027E, growing 19.04% annually versus 1.7% for outsourced CX.
Fusion CX plans Rs 61.146 crore of Arya and MindVoice upgrades through Fiscal 2029, including Rs 33.398 crore for platform and partner costs.
Fusion CX faces a pending US$6 million purchase-price lawsuit over its Sequential Technology International acquisition, while its subsidiary alleges US$3.53 million of undisclosed liabilities.
Fusion BPO reports three material subsidiaries with negative net worth, led by Sequential Technology International LLC at Rs 240.337 crore at June 30, 2026.
Fusion CX advanced Rs 28.415 crore to two promoter-group companies in the June 2026 quarter, with PKR Services Inc. receiving Rs 20.64 crore.